Dr. Paul H. Schipper is a cardiothoracic and thoracic surgeon with OHSU Health and a member of the lung cancer team at the Knight Cancer Institute. He specializes in chest and lung surgery, with a special focus on esophageal cancer, lung cancer, minimally invasive thoracic surgery, thymoma, and thymic malignancies. He pioneered the use of
Dr. Raid Aljumaily is a medical oncologist with a special interest in thoracic oncology. He practices at the Stephenson Cancer Center of Oklahoma University Health in the Department of Hematology/Oncology, treating patients diagnosed with lung cancer, pleural mesothelioma, and other thoracic malignancies. Dr. Aljumaily’s practice is guided by his scientific background, and he works to
Dr. Jess Schwartz is a thoracic surgeon with extensive specialty training in minimally invasive surgical techniques, including robotic and video-assisted thoracic surgery. He deploys these skills at the Stephenson Cancer Center and Oklahoma University Health in Oklahoma City, Oklahoma, caring for patients with thoracic malignancies, specializing in treating patients with lung cancer, esophageal cancer, mediastinal
Dr. J. Matthew Reinersman is a thoracic surgeon and thoracic oncologist who treats patients with lung cancer, malignant pleural mesothelioma, esophageal cancer, and other types of thoracic malignancies at the Stephenson Cancer Institute at Oklahoma University. He specializes in using robotic technology and minimally invasive surgical techniques to improve patient outcomes and minimize adverse effects.
Medical researchers are relentlessly searching for answers to the puzzle of malignant mesothelioma, the rare and deadly asbestos-related disease that has proven so resistant to traditional cancer treatments. A recent discovery by researchers in Germany has provided an important piece of the puzzle: The scientists have identified a biomarker that is both more accurate than
Dr. Kai He is an innovative medical oncologist who specializes in the care of lung cancer and malignant pleural mesothelioma patients at the James Cancer Hospital of The Ohio State University. Dr. He’s expertise lies in providing personalized care based on his patients’ unique clinical, genetic, and immunological characteristics. Dr. He is also a physician-scientist
Dr. David P. Carbone is a medical oncologist who specializes in treating patients with lung cancer and other thoracic malignancies at the James Cancer Hospital of the Ohio State University Comprehensive Cancer Center. Dr. Carbone is Director of the hospital’s thoracic center and co-leader of the Translational Therapeutics Program at the Ohio State University Comprehensive
Dr. Gregory A. Otterson is a thoracic oncologist at the James Cancer Hospital in Columbus, Ohio and clinical director of the Thoracic Oncology Disease specific Research Group at the Ohio State University Comprehensive Cancer Center – James. He specializes in the treatment of patients with thoracic malignancies, including malignant pleural mesothelioma, adenocarcinoma, and thymic cancers,
Dr. Dwight Owen is a medical oncologist at the James Cancer Hospital and a researcher at the Ohio State University Comprehensive Cancer Center in Columbus, Ohio. He specializes in treating patients with thoracic malignancies, including malignant pleural mesothelioma, lung cancer, and thymic cancers. Dr. Owen says that what drove him into oncology was the human
Dr. Peter G. Shields is a medical oncologist and researcher at The Ohio State University Comprehensive Cancer Center and the James Cancer Hospital. He is a tenured professor in the Department of Internal Medicine at The Ohio State University College of Medicine and in the Division of Epidemiology at The Ohio State University College of